The Women’s Health Clinical Research Center at Penn Medicine is currently recruiting participants with sickle cell disease for a paid study looking at whether participants experience any difference in their sickle cell pain while using a hormonal birth control implant as compared to when not using this birth control method. The implant, known as Nexplanon, is currently FDA approved, releases a small amount of hormone every day, and is the most effective form of hormonal…